Oramed Pharmaceuticals Welcomes New Audit Committee Chair
TipRanksMar 18 17:33 ET
Oramed Pharmaceuticals Updates Stock Sale Strategies and Partners
TipRanksMar 18 17:23 ET
Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
Yahoo FinanceMar 9 09:32 ET
Oramed Plans New US Trial for Oral Insulin After Setback, Partners With HTIT to Commercialize Products
InvestingFeb 20 08:56 ET
Oramed Pharmaceuticals CEO Updates Shareholders on Strategy
TipRanksFeb 20 08:52 ET
MQ, ORMP and EXAI Are Among Pre Market Gainers
Seeking AlphaFeb 12 08:34 ET
Top 4 Health Care Stocks That May Crash This Quarter
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator
BenzingaFeb 2 08:21 ET
Express News | Oramed Pharmaceuticals Parties Intend For JV To Initiate Phase 3 Oral Insulin Trial In The U.S.; Oramed Will Be Entitled To Receive A 3% Royalty On Gross Revenues Of JV Generated From Oramed Related Assets
Moomoo 24/7Jan 23 16:51 ET
Express News | Oramed Pharmaceuticals Said On Jan 22, Co And Unit Entered Into Joint Venture Agreement With Hefei Tianhui Biotech And Technowl; Oramed And HTIT Will Initially Hold Equal Shares In JV, With Each Owning 50% Of Equity
Moomoo 24/7Jan 23 16:50 ET
PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization
PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 ...
PR NewswireOct 24, 2023 08:30 ET
OKTA, AMWL and ORMP Among Pre-market Losers
Seeking AlphaOct 23, 2023 08:31 ET
Oramed Pharmaceuticals (NASDAQ:ORMP) Investors Are Sitting on a Loss of 63% If They Invested a Year Ago
Yahoo FinanceOct 6, 2023 09:51 ET
Oramed Pharmaceuticals Secures $101.9M Senior Secured Note Deal With Scilex
An initial principal balance of $101,875,000.00;A senior lien for Oramed on substantially all assets of Scilex and its subsidiaries, subject to certain exclusions;18-month maturity;Certain mandatory p
BenzingaSep 22, 2023 01:35 ET
Press Release: Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction With Scilex Holding Company
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company PR Newswire NEW YORK, Sept. 21, 2023 -- 18-month loan with interest rate of SOFR plus 8.5%
Dow JonesSep 21, 2023 18:11 ET
Scilex Assumed $100M In Debt Owed To Oramed Pharmaceuticals And Issued A Promissory Note And Warrants To Oramed As Part Of The Securities Transfer.
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for t
BenzingaSep 21, 2023 16:15 ET
Scilex Holding Company Announces The Consummation Of The Previously Announced Purchase Of All Of The Scilex Common Shares, Preferred Shares And Warrants Owned By Sorrento Therapeutics, Inc.
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for t
BenzingaSep 21, 2023 16:15 ET
Scilex to Acquire Sorrento-owned Stake
Seeking AlphaSep 13, 2023 15:45 ET
Scilex Holding Company Enters Non-Binding Term Sheets For The Purchase Of All Of The Scilex Common Shares, Preferred Shares, And Warrants Currently Owned By Sorrento Therapeutics, Inc. And Is Declared New Successful Bidder
Scilex Holding Company Enters Non-Binding Term Sheets For The Purchase Of All Of The Scilex Common Shares, Preferred Shares, And Warrants Currently Owned By Sorrento Therapeutics, Inc. And Is Declared
BenzingaSep 13, 2023 09:02 ET
Sorrento Granted Court Approval to Sell Scilex Stock
Seeking AlphaAug 8, 2023 12:05 ET
Oramed to Form Joint Venture With China-based Hefei Tianhui Biotech
Seeking AlphaAug 2, 2023 08:30 ET
No Data
No Data